Related Experiment Video
Updated: Sep 28, 2025

Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
A Series of COVID-19 Cases With Findings in the Gastrointestinal and Hepatobiliary System
Dongling Wu1, Sean Hacking2, Lili Lee3
1Pathology and Laboratory Medicine, Northwell Health, Northshore Long Island Jewish Hospital, Manhasset, USA.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause gastrointestinal issues, including ischemic necrosis and acute cholecystitis. These cases show SARS-CoV-2 infection can lead to severe gastrointestinal and hepatobiliary disease.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pathology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, primarily affects the respiratory system.
- Gastrointestinal symptoms are less commonly reported but can be severe.
Observation:
- Three COVID-19 cases presented with primary gastrointestinal and hepatobiliary symptoms.
- Histological findings included ischemic necrosis of the small bowel and microvascular thrombosis in acute cholecystitis.
Findings:
- SARS-CoV-2 infection can manifest with severe gastrointestinal and hepatobiliary disease.
- Ischemic and thrombotic changes are key pathological features in these cases.
- The small intestine and gallbladder were infected, likely via the ACE2 receptor.
Implications:
- Highlights the potential for severe gastrointestinal and hepatobiliary complications of COVID-19.
- Suggests a need for considering COVID-19 in patients with unexplained gastrointestinal and hepatobiliary issues.
- Underscores the role of SARS-CoV-2 in vascular complications beyond the respiratory tract.
Abstract:
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide. Most of the infected patients present with respiratory symptoms and acute lung damage. Here, we present three cases of patients with COVID-19 disease whose main clinical manifestations are gastrointestinal symptoms. In our first case, we present a COVID-19 patient with histologic findings associated with ischemic necrosis of the small bowel. In the second and third cases, we demonstrate acute cholecystitis and histology showing microvascular thrombosis. These three cases highlight the ischemic and thrombotic changes seen in the setting of COVID-19 infection without classic respiratory symptoms, with resulting severe gastrointestinal and hepatobiliary disease requiring surgical management. Although the bile or stool viral load was not tested in these patients, the small intestine and gallbladder were infected with SARS-CoV-2, most likely via the epithelial angiotensin-converting enzyme 2 (ACE2) receptor.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Serum Laboratory Studies, Stool Test, Breath Test
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...